Cargando…
Study protocol: the ILANA study – exploring optimal implementation strategies for long-acting antiretroviral therapy to ensure equity in clinical care and policy for women, racially minoritised people and older people living with HIV in the UK – a qualitative multiphase longitudinal study design
INTRODUCTION: Cabotegravir and rilpivirine (CAB+RPV long-acting (LA)) is recommended as a treatment for HIV-1 allowing people living with HIV to receive 2 monthly injectable treatment, rather than daily pills. Providing injectable therapy in a system designed to provide and manage study participants...
Autores principales: | Farooq, Hamzah Z, Apea, Vanessa, Kasadha, Bakita, Ullah, Sadna, Hilton-Smith, Gill, Haley, Amber, Scherzer, Jenny, Hand, James, Paparini, Sara, Phillips, Rachel, Orkin, Chloe M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335540/ https://www.ncbi.nlm.nih.gov/pubmed/37423623 http://dx.doi.org/10.1136/bmjopen-2022-070666 |
Ejemplares similares
-
Patient-generated data in the management of HIV: a scoping review
por: Hewitt, Clara, et al.
Publicado: (2021) -
Qualitative study of the BREATHER trial (Short Cycle antiretroviral therapy): is it acceptable to young people living with HIV?
por: Bernays, Sarah, et al.
Publicado: (2017) -
Application of the multiphase optimisation strategy (MOST) to optimise HIV prevention targeting people on medication for opioid use disorder (MOUD) who have cognitive dysfunction: protocol for a MOST study
por: Mistler, Colleen B, et al.
Publicado: (2023) -
A/C study protocol: a cross-sectional study of HIV epidemiology among African, Caribbean and Black people in Ontario
por: Mbuagbaw, Lawrence, et al.
Publicado: (2020) -
Qualitative study exploring the experiences and perceptions of dolutegravir/lamivudine dual antiretroviral therapy (the PEDAL study) in people living with HIV: protocol
por: Villa, Giovanni, et al.
Publicado: (2022)